Provided by Tiger Trade Technology Pte. Ltd.

Global X Aging Population ETF

36.93
-0.0850-0.23%
Post-market: 36.990.0650+0.18%19:56 EDT
Volume:5K
Turnover:183.64K
Market Cap:91.19M
PE:- -
High:37.08
Open:37.08
Low:36.83
Close:37.01
52wk High:39.48
52wk Low:32.44
Shares:2.47M
Float Shares:2.47M
Volume Ratio:0.39
T/O Rate:0.20%
Dividend:0.33
Dividend Rate:0.89%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Ulanqab Municipal Market Regulation Bureau Advances Medical Device Quality Control Sampling in 2026

Deep News
·
Sep 16

Actinogen Medical Options Expire, Streamlining ASX-Listed Capital Structure

TIPRANKS
·
Sep 16

Cambium Bio Plans New Share Placement to Bolster Capital Base

TIPRANKS
·
Sep 16

Healthpeak Properties Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 16

Ventas Appoints Laurida Sayed as Chief Accounting Officer

TIPRANKS
·
Sep 16

Thatch Raises $108 Million at $1 Billion Valuation

Reuters
·
Sep 16

Thatch: Funding & Participation from the General Partnership, General Catalyst, Andreessen Horowitz, ADP Ventures, Eli Lilly & Others

THOMSON REUTERS
·
Sep 16

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Sep 15

Ventas Coverage Assumed by Jefferies at Buy

Dow Jones
·
Sep 15

Sichuan Shuangma Expands CDMO Operations Into Major Western Markets, Secures Partnerships With Multiple US and European Biotech Firms

Deep News
·
Sep 15

Eli Lilly Stock (LLY) Gets New Buy Rating as Weight-Loss Drug Sales Accelerate

TIPRANKS
·
Sep 15

Abbvie Exec Says Will Present Late-Stage Data for Blood Cancer Drug Etentamig at International Myeloma Society Meeting Later in September - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Existing Portfolio Provides 'Clear Line of Sight' to Very Strong Growth Well into Next Decade - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Apogee Fits 'Very Nicely' with Its Business Development Approach - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Plans to Start Enrolling Apogee's Zumilokibart This Year, Targets Launch in Early 2030 - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Tavapadon U.S. Launch Expected to Have 'Slower Burn' Due to Timing of Medicare Reimbursement - Conf Call

THOMSON REUTERS
·
Sep 15

Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy

Dow Jones
·
Sep 15

U.S. Stocks on the MOVE-Eli Lilly, Waystar, Sysco

Reuters
·
Sep 15

Jiangsu Cowin Biotech Secures Class III Medical Device Certification for Clostridioides Difficile Detection Kit

Stock News
·
Sep 15

Shanghai Kehua Bio-Engineering Secures Regulatory Approvals for Two New Diagnostic Kits

Stock News
·
Sep 15